SEER, INC. Payments to Acquire Debt Securities, Available-for-sale
SEER, INC. (SEER) reported Payments to Acquire Debt Securities, Available-for-sale of $77.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-11
- SEER, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $29.53M, a 21.27% decline year-over-year.
- SEER, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $48.45M, a 22.67% decline year-over-year.
- SEER, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $27.36M, a 49.05% decline year-over-year.
- SEER, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $45.63M, a 12.14% increase year-over-year.
- SEER, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $173.17M, a 34.14% decline from fiscal 2024.
- SEER, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $262.93M, a 34.77% decline from fiscal 2023.
- SEER, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $403.09M, a 10.05% increase from fiscal 2022.
- SEER, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $366.27M, a 30.83% increase from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $77.98M 10-Q · filed 2026-08-11 | $105.35M derived: sum of 3 quarters · filed 2026-08-11 | $150.98M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $48.45M 10-Q · filed 2026-05-13 | $75.82M derived: sum of 2 quarters · filed 2026-05-13 | $121.45M derived: sum of 3 quarters · filed 2026-05-13 | $158.96M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $27.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $73.00M derived: sum of 2 quarters · filed 2026-03-02 | $110.51M derived: sum of 3 quarters · filed 2026-08-11 | $173.17M 10-K · filed 2026-03-02 |
| 2025-09-30 | $45.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $83.14M derived: sum of 2 quarters · filed 2026-08-11 | $145.81M 10-Q · filed 2025-11-06 | $199.52M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $37.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $100.17M 10-Q · filed 2026-08-11 | $153.89M derived: sum of 3 quarters · filed 2026-08-11 | $194.58M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $62.66M 10-Q · filed 2026-05-13 | $116.37M derived: sum of 2 quarters · filed 2026-05-13 | $157.06M derived: sum of 3 quarters · filed 2026-05-13 | $224.29M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $53.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $94.40M derived: sum of 2 quarters · filed 2026-03-02 | $161.63M derived: sum of 3 quarters · filed 2026-03-02 | $262.93M 10-K · filed 2026-03-02 |
| 2024-09-30 | $40.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $107.92M derived: sum of 2 quarters · filed 2025-11-06 | $209.21M 10-Q · filed 2025-11-06 | $294.26M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $67.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $168.52M 10-Q · filed 2025-08-06 | $253.57M derived: sum of 3 quarters · filed 2025-08-06 | $301.75M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $101.30M 10-Q · filed 2025-05-13 | $186.34M derived: sum of 2 quarters · filed 2025-05-13 | $234.52M derived: sum of 3 quarters · filed 2025-05-13 | $369.87M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $85.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $133.22M derived: sum of 2 quarters · filed 2025-03-03 | $268.57M derived: sum of 3 quarters · filed 2025-03-03 | $403.09M 10-K · filed 2025-03-03 |
| 2023-09-30 | $48.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $183.53M derived: sum of 2 quarters · filed 2024-11-06 | $318.05M 10-Q · filed 2024-11-06 | $481.57M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $135.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $269.87M 10-Q · filed 2024-08-08 | $433.39M derived: sum of 3 quarters · filed 2024-08-08 | $492.49M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $134.52M 10-Q · filed 2024-05-08 | $298.04M derived: sum of 2 quarters · filed 2024-05-08 | $357.14M derived: sum of 3 quarters · filed 2024-05-08 | $500.79M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $163.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $222.62M derived: sum of 2 quarters · filed 2024-03-04 | $366.27M derived: sum of 3 quarters · filed 2024-03-04 | $366.27M 10-K · filed 2024-03-04 |
| 2022-09-30 | $59.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $202.75M derived: sum of 2 quarters · filed 2023-11-07 | $202.75M 10-Q · filed 2023-11-07 | $312.90M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $143.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $143.65M 10-Q · filed 2023-08-08 | $253.81M derived: sum of 3 quarters · filed 2023-08-08 | $294.29M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $110.16M derived: sum of 2 quarters · filed 2023-05-09 | $150.64M derived: sum of 3 quarters · filed 2023-05-09 | $249.68M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $110.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $150.64M derived: sum of 2 quarters · filed 2023-03-06 | $249.68M derived: sum of 3 quarters · filed 2023-03-06 | $279.96M 10-K · filed 2023-03-06 |
| 2021-09-30 | $40.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $139.52M derived: sum of 2 quarters · filed 2022-11-08 | $169.80M 10-Q · filed 2022-11-08 | $181.90M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $99.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $129.32M 10-Q · filed 2022-08-09 | $141.42M derived: sum of 3 quarters · filed 2022-08-09 | $213.61M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $30.28M 10-Q · filed 2022-05-06 | $42.38M derived: sum of 2 quarters · filed 2022-05-06 | $114.57M derived: sum of 3 quarters · filed 2022-05-06 | $114.52M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $84.29M derived: sum of 2 quarters · filed 2022-03-01 | $84.24M derived: sum of 3 quarters · filed 2022-03-01 | $87.72M 10-K · filed 2022-03-01 |
| 2020-09-30 | $72.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $72.14M derived: sum of 2 quarters · filed 2021-11-09 | $75.62M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.44M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $3.48M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |